UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  April 27, 2015

 

 

SELECT MEDICAL HOLDINGS CORPORATION
SELECT MEDICAL CORPORATION

 

 

(Exact name of registrant as specified in its charter)

 

Delaware

Delaware

 

001-34465
001-31441

 

20-1764048
23-2872718

(State or other jurisdiction of
Incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer

Identification No.)

 

 

4714 Gettysburg Road, P.O. Box 2034

Mechanicsburg, PA 17055

(Address of principal executive offices) (Zip Code)

 

(717) 972-1100

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07                   Submission of Matters to a Vote of Security Holders.

 

The annual meeting of stockholders (the “Annual Meeting”) of Select Medical Holdings Corporation (the “Company”) was held on April 27, 2015.  At the Annual Meeting, the Company’s stockholders approved three proposals.  The proposals below are described in the Company’s definitive proxy statement dated March 4, 2015.  The results are as follows:

 

Proposal 1: The Election of Three Class III Directors to the Board of Directors

 

Name

 

Votes For

 

Votes Withheld

 

Abstentions

 

Broker Non-Votes

James E. Dalton, Jr.

 

108,550,382

 

14,120,693

 

0

 

4,802,536

Rocco A. Ortenzio

 

114,930,882

 

7,740,193

 

0

 

4,802,536

Thomas A. Scully

 

106,897,812

 

15,773,263

 

0

 

4,802,536

 

Proposal 2:  Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

100,499,447

 

21,287,539

 

884,089

 

4,802,536

 

Proposal 3:  Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2015

 

Votes For

 

Votes Against

 

Abstentions

 

Broker Non-Votes

126,581,490

 

211,994

 

680,127

 

0

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.

 

 

SELECT MEDICAL HOLDINGS CORPORATION

 

SELECT MEDICAL CORPORATION

 

 

 

 

 

 

Date: April 29, 2015

By:

/s/ Michael E. Tarvin

 

 

Michael E. Tarvin

 

 

Executive Vice President, General Counsel and Secretary

 

3